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Abstract
Background: A general internist has an important role in primary care, especially for the elderly in rural areas of Japan. 
Although effective intervention models for depressed patients in general practice and primary care settings have been 
developed in the US and UK medical systems, there is little information regarding even the recognition rate and 
prescription rate of psychotropic medication by general internists in Japan. The present study surveyed these data 
cross-sectionally in a general internal medicine outpatient clinic of a Japanese rural hospital.
Methods: Patients were consecutively recruited and evaluated for major depressive disorder or any mood disorder 
using the Patient Health Questionnaire (PHQ). Physicians who were blinded to the results of the PHQ were asked to 
diagnose whether the patients had any mental disorders, and if so, whether they had mood disorders or not. Data 
regarding prescription of psychotropic medicines were collected from medical records.
Results: Among 312 patients, 27 (8.7%) and 52 (16.7%) were identified with major depressive disorder and any mood 
disorder using the PHQ, respectively. Among those with major depressive disorder, 21 (77.8%) were recognized by 
physicians as having a mental disorder, but only three (11.1%) were diagnosed as having a mood disorder.
Only two patients with major depressive disorder (7.4%) had been prescribed antidepressants. Even among those (n
= 15) whom physicians diagnosed with a mood disorder irrespective of the PHQ results, only four (26.7%) were
prescribed an antidepressant.
Conclusions: Despite a high prevalence of depression, physicians did not often recognize depression in patients. In 
addition, most patients who were diagnosed by physicians as having a mood disorder were not prescribed 
antidepressants. Multiple barriers to providing appropriate care for depressed patients exist, such as recognizing 
depression, prescribing appropriate medications, and appropriately referring patients to mental health specialists.
Background
Depression is a common and chronic psychiatric disor-
der. It is estimated that depression will become the lead-
ing cause of disability worldwide in 2030 [1]. In middle-
income and high-income countries including Japan,
depression was the leading cause of disability in 2004 [1].
Depression is associated with impaired quality of life, yet
many depressed patients do not receive appropriate care
[2]. The importance of early detection and appropriate
care for depressed patients has only recently been recog-
nized.
In the United States and United Kingdom, primary care
physicians and general practitioners (GPs) have an
important role in diagnosing and treating depressed
patients [3,4]. In countries with a primary care system,
the importance of developing effective depression man-
agement models for primary care settings has been
emphasized to provide appropriate care for depressed
patients. Collaborative care has emerged as a potentially
effective intervention for improving the quality of pri-
mary care and patient outcomes, primarily in the US. The
effectiveness of collaborative care has been shown in a
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sion management models have been developed and intro-
duced on site in these countries. These models are
developed based on situation-specific parameters such as
prevalence of depression, recognition rate of depressed
patients by physicians, prescription rate of antidepres-
sants to depressed patients, and referral rate to mental
health specialists. However, little information necessary
for developing effective intervention models is available
in Japan.
In Japan, there are few specialists for primary care or
general practice because the Japanese medical system has
no clear definition regarding the role of primary care and
the specific provider responsible. Patients do not need to
consult with assigned primary care providers as in the UK
medical system. In the Japanese system, patients select
hospitals using their own judgment and usually consult
general internists, as well as any other specialist, directly.
In rural areas, most patients consult a general internist
who plays a role similar to that of a primary care physi-
cian in the UK. It has been reported that depressed
patients in Japanese communities tend to consult not
only mental health specialists, but also other specialists
such as a general internists because of their somatization
in addition to the stigmatization of psychiatric disorders
and services [6,7]. The importance of primary care pro-
vided by general internists in the management of
depressed patients has been stated recently in the Com-
prehensive Suicide Prevention Initiative published by the
Japanese Government. This publication was based on
effective intervention models and guidelines for depres-
sion care in primary care settings and general practice
developed in the US and UK medical systems [8].
A survey examining the prevalence of depression and
the recognition rate of depressed patients by physicians
was performed nearly 20 years ago. The survey was con-
ducted at general internal medicine outpatient clinics in
general hospitals in medium-sized cities of Japan and the
patients in the survey were 15-65 years old. The recogni-
tion rate of depression by physicians in this survey was
lower than in other countries at 19.3% [9]. However, the
situation has changed recently as the number of
depressed patients receiving medical care has increased
[10]. Because of this change in situation, there are no
usable data suitable for developing intervention models
reflecting the role of primary care in a general internal
medicine outpatient clinic in Japanese rural areas.
Meanwhile, the prevalence of chronic medical illness in
the elderly is high. Given that a higher prevalence of
depression has been reported in patients with chronic
medical illnesses [11], general internists have an impor-
tant role in diagnosing depression among older people,
especially in rural areas with a high population aging rate.
Also from this perspective, information regarding general
internal medicine in rural areas is important.
In the present study, we conducted a survey investigat-
ing the prevalence of depression in addition to the ability
to recognize depression and rates of psychotropic pre-
scription at a general internal medicine outpatient clinic
in a rural hospital. These rates are important indices of
each step - diagnosis, judging the care that is necessary,
and treating and/or referring the patient to mental health
specialists - in the provision of appropriate care for




This study was approved by the ethics committee of the
National Center of Neurology and Psychiatry in Japan.
The researchers provided all participants with detailed
information of the study in the form of a written docu-
ment. The study was performed after obtaining the
patients' oral informed consent.
This study was conducted on 6 of 10 consultation days
between June 15 and 26, 2009, at a general internal medi-
cine outpatient clinic in a general hospital having no
mental health services. This hospital is located in Oshu
City, Iwate Prefecture in the Tohoku region of Japan. The
hospital is functioning as a regional public hospital and is
funded by the National Health Insurance Society at Oshu
City. Oshu City is a typical rural area about 500 km north
of Tokyo with low influx and efflux of the population.
There are high proportions of elderly people and people
engaged in primary industry [12].
Participants
All patients aged 20 or older who visited the outpatient
clinic to consult a physician were recruited consecutively.
Visitors who consulted for family members or others and
patients who had already participated in the survey were
excluded. Patients with significant cognitive impairment,
those who were unable to understand Japanese, and those
who had physical or mental conditions too severe to par-
ticipate in the survey were excluded. Cognitive impair-
ment was judged by research staff (trained psychiatric
nurses, psychiatrists, or trained investigators), based on a
semi-structured interview that including asking patients
questions such as, "What is the date today?" and "Did you
come here by yourself?". The staff sometimes conducted
an additional interview regarding the patients' life style
and history of dementia if accompanying persons were
present.
Figure 1 shows the number of patients included and
excluded at each stage of the present study. Of 427
patients who consulted the general internal medicine
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fulfilled the inclusion criteria and gave informed consent.
Three patients had deficits in one or several items of the
Patient Health Questionnaire (PHQ: described below)
that were needed to evaluate depressive disorders. The
questionnaires regarding physician recognition of mental
disorders (described below) could not be collected for 4
patients. As a result, we used information from 312
patients in our analyses. The number (%) of patients who
could not be contacted, and the number of patients who
refused to participate or dropped out from the study were
10 (3.0%) and 14 (4.2%), respectively. The information
about sex and age of patients who refused to participate
was not collected. Among the seven patients who
dropped out from the study, five (71.4%) were female. Age
of one patient was unknown, and the mean (standard
deviation: SD) age of the six patients was 73.2 (8.4) years.
Five male physicians (mean (SD) age, 44.4 (10.6) years),
all of whom had their clinical duties at the outpatient
clinic, examined patients at the general internal medicine
department in the hospital. Each day, two physicians
worked at the routine outpatient clinic in the morning
and two others worked there in the afternoon. Each phy-
sician saw approximately 15-20 patients, with the four
physicians seeing a total of about 60-80 patients in one
day.
Procedure
We approached outpatients visiting the department of
general internal medicine during the survey days listed
above. Candidate participants who provided informed
consent answered several self-report questionnaires dur-
ing the waiting period for consultation as described in the
Measures section below. These questionnaires were used
to assess psychiatric disorders, and to survey sociodemo-
graphic information and treatment history of mental dis-
orders. Physicians who were blinded to the results of the
questionnaires were asked about the diagnosis of primary
illness and recognition of mental disorders for each
patient after consultation. The history of psychotropic
medicine prescription for each patient was collected after
the consultation day.
Measures
Clinical diagnosis of primary illness
The clinical diagnosis of primary illness for each patient
was made by physicians using a questionnaire that
allowed multiple answers and the freedom to provide
description.
Recognition of mental disorders by physicians
We evaluated the recognition of mental disorders by phy-
sicians for each patient using a questionnaire. If any men-
tal disorders were recognized by the physician, a clinical
psychiatric diagnosis and the impression of severity were
determined by the physician using the following proce-
dure. Clinical psychiatric diagnoses were selected from
the following terms: mood disorder, anxiety disorder,
alcohol-related disorder, insomnia, dementia, other, and
uncategorizable. Multiple selections were allowed. The
"other" category included psychiatric disorders or symp-
toms other than those listed above, and "uncategorizable"
indicated that physicians could not clinically diagnose the
psychiatric disorder. These terms were determined dur-
ing a discussion among physicians and researchers prior
to the survey period. Because recognition of mental dis-
orders by physicians was intended to reflect clinical diag-
noses used daily, not only clinical psychiatric diagnoses
but any psychiatric symptoms observed were included as
recognition of mental disorders. We defined the severity
of mental disorders as the degree of influence on daily
life, similar in concept to the Global Assessment of Func-
tioning (GAF) scale in the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV)
[13]. The physician's judgment concerning the severity of
mental disorders was recorded using a 5-point scale rang-
ing from "5 = extremely severe" to "1 = mild," with
patients having no mental disorders scored as a zero.
Prescription of psychotropic medicine
Data regarding history of psychotropic medicine pre-
scription for all patients on the consultation (survey) day
and during the previous 6 months were collected from
medical records after the consultation day by two
researchers including a psychiatrist (MI and TO).
Figure 1 Sampling Process.
427 consulted physician in a
general internal medicine
outpatient clinic
59 did not fulfill inclusion criteria  
 · aged under 20 years old (n=10)
 · no consultation for oneself (n=9)
 · multiple contacts (n=40)
368 fulfilled inclusion criteria
32 l d d were exc u e
 · dementia (n=25)
 · physical/mental disease too severe (n=5)
· loss of information about exclusion reason (n=2)
10 could not be contacted
326 were eligible patients 
7 refused to give informed consent
319 gave informed consent
(participants)
3 did not complete depression module of the PHQ
316 were assessed for
depressive disorders by the
PHQ
li i l di t ll t d b th h i ic n ca  agnoses were no  co ec e  y e p ys c an
(n=4)
312 were used to this analysis
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History of referral to mental health specialists during the
previous 6 months was surveyed from medical records
after the consultation day for all patients evaluated as
having any mood disorder using the PHQ described
below.
Depressive disorders and other psychiatric comorbidities
We used the Japanese version of the Patient Health Ques-
tionnaire (PHQ) to assess depressive disorders [14]. The
PHQ is a self-report version of the Primary Care Evalua-
tion of Mental Disorders (PRIME-MD) [15] that was
developed as a primary care screening tool for common
mental disorders, including major depressive disorder
and probable alcohol abuse or dependence [16,17]. The
PHQ has been used in studies all over the world [18,19].
The Japanese PHQ was developed and its validity was
assessed using the Mini-International Neuropsychiatric
Interview-Plus [14]. We used a 9-item depression module
of the Japanese PHQ to assess major depressive disorder
and other depressive disorders. Clinical significance of
major depressive disorder and other depressive disorders
was assessed using a categorical algorithm for the PHQ
depressive module. Patients were assessed as having
major depressive disorder if they responded "more than
half the days" or higher to five or more of the nine items
(Questions 1a-1i). Question 1i was included in this total if
their response was at least "several days." In addition, the
five items had to include either Question 1a or 1b. A
patient was considered to have another depressive disor-
der if they responded with at least "more than half the
days" to two, three, or four of the nine items. Again,
Question 1i was included in the total items if it received
at least "several days", and one of the items had to include
either Question 1a or 1b. Patients were considered to
have "any mood disorder" when evidence for both major
depressive disorder and another depressive disorder was
present. The sensitivity and specificity of major depres-
sive disorder were 84% and 95%, respectively [14]. The
sensitivity and specificity of any mood disorder were 75%
and 94%, respectively (unpublished data analyzed from
the data set used in the reference [14]). The severity of
depressive disorder was assessed using the summary
score (0-27) of each item of the depressive module of the
PHQ.
As additional information, we assessed three psychiat-
ric comorbidities: panic disorder, alcohol-related disor-
der, and generalized anxiety disorder. We used the panic
disorder module of the brief PHQ, a simplified version of
the PHQ, to assess panic disorder [16]. Although a Japa-
nese version of the brief PHQ has been developed by
reverse translation, the validity data have not been
reported. We used the probable alcohol abuse or depen-
dence module of the PHQ to assess alcohol-related disor-
der. The sensitivity and specificity of probable alcohol
abuse or dependence in Japanese were 100% and 95%,
respectively [14]. We used the Japanese version of the 7-
item generalized anxiety disorder scale (GAD-7) to assess
generalized anxiety disorder. The GAD-7 is a brief self-
report questionnaire used as a screening tool for GAD in
clinical practice [20]. Similar to the PHQ, the Japanese
version GAD-7 has been developed by reverse transla-
tion. Sensitivity and specificity of the Japanese version
GAD-7 are 88% and 82%, respectively [21].
Analysis
We calculated the prevalence and 95% confidence inter-
vals of major depressive disorder and any mood disorder.
The recognition rate of mood disorder by physicians and
the prescription rate of psychotropic medicine were each
calculated as a ratio among patients evaluated as having
major depressive disorder and any mood disorder using
the PHQ.
We assessed the relationship between the severity of
depressive disorder evaluated by the PHQ and the sever-
ity of mental disorders based on the physician's judgment
using Pearson's correlation coefficient. A two-sided P-
value < 0.05 was considered significant. We performed
statistical analyses using SPSS version 17.0J (SPSS Japan
Inc.)
Results
Characteristics of the patients who participated in the 
present study
Among the 312 patients, 193 (61.9%) were female. The
median (range) and mean (SD) age were 75 (21-98) and
72.9 (12.5) years. The most common diagnosis of primary
illness was hypertension, followed by hyperlipidemia and
diabetes (Table 1). Five patients consulted the physician
only for mental disorders.
The number and prevalence of patients with major
depressive disorder and any mood disorder as assessed by
the PHQ are shown in Table 2. The number and preva-
lence of patients diagnosed with panic disorder, alcohol-
related disorder, and GAD were 3 (1.0%), 23 (7.4%), and
16 (5.2%), respectively.
The number and prevalence of patients with major
depressive disorder comorbid with panic disorder, alco-
hol-related disorders, and GAD were 2 (7.7%), 1 (4.0%),
and 5 (19.2%), respectively. For patients with any mood
disorder comorbid with panic disorder, alcohol-related
disorders, and GAD, the number and prevalence were 2
(4.0%), 3 (6.4%), and 9 (18.4%), respectively.
Recognition of mental disorders by physicians
Physicians clinically diagnosed 85 patients as having a
mental disorder. The clinical psychiatric diagnoses (num-
ber of patients) made by the physicians included the fol-
lowing: mood disorder (15), anxiety disorder (17),
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other (13) and uncategorizable (4).
Among the 27 patients identified with major depressive
disorder using the PHQ, physicians recognized 21
patients (77.8%) as having a mental disorder. The clinical
psychiatric diagnoses made by the physicians for these 21
patients are shown in Table 3. Among the 27 patients
with major depressive disorder, only three patients
(11.1%) were correctly recognized by physicians as having
a mood disorder. Many patients with major depressive
disorder were clinically diagnosed with insomnia by phy-
sicians.
Meanwhile, among the 52 patients diagnosed with any
mood disorder using the PHQ, physicians recognized 31
patients (59.6%) as having a mental disorder. The clinical
psychiatric diagnoses made by the physicians for these 31
patients are shown in Table 4. Among the 52 patients
with any mood disorder, physicians recognized only
seven patients (13.5%) as having a mood disorder.
Among the 85 patients who were recognized by physi-
cians as having a mental disorder, the physicians judged
the severity of the mental disorders (number of patients)
as follows: extremely severe (1), moderately severe (7),
moderate (20), moderately mild (30), or mild (24). The
severity scores for three patients were blank.
Among patients identified with any mood disorder
using the PHQ, the relationship between depression
severity using the PHQ summary score and the severity
of the mental disorder as judged by the physician was sig-
nificant (Pearson's correlation coefficient r = 0.346, p =
0.012). Among the 27 patients with major depressive dis-
order, 12 patients had moderately severe depression
(summary score of the PHQ: 15-19) or severe depression
(20-27). Among these, physicians judged seven patients
(58.3%) as having a moderately mild or a mild mental dis-
order, or no mental disorders. In short, physicians under-
estimated the severity of their disorders.
Prescription of psychotropic medicine by physicians
The survey of psychotropic prescription history showed
that 13 (4.2%) patients were prescribed any antidepres-
sant including sulpiride, which is permitted by insurance
as a drug for depression in the Japanese health system,
and 72 (23.1%) were prescribed an anxiolytic or hypnotic.
Two patients had been prescribed an antiepileptic. The
numbers (%) of psychotropic medicine prescriptions in
patients identified with major depressive disorder and
any mood disorder using the PHQ are shown in Table 5.
Among the 27 patients with major depressive disorder,
only one patient had been prescribed an antidepressant
by a physician and another patient was prescribed an
antidepressant by another outpatient clinic (orthopedic
department) in the same hospital. In addition to the two
patients prescribed antidepressants by physicians, one
patient had been prescribed an antidepressant from
another hospital. As a result, only three patients with
major depressive disorder had received any antidepres-
sants.
Even among those who were clinically diagnosed as
having mood disorders by physicians irrespective of the
PHQ depression score (n = 15: three with major depres-
sive disorder, four with other depressive disorder, and
eight without any mood disorder), only four (26.7%) were
prescribed an antidepressant.
Additionally, according to medical records, none of the
patients identified with any mood disorder using the
PHQ had been referred to a mental health specialist.
Discussion
PHQ results from patients visiting a general internal
medicine outpatient clinic of a rural hospital showed that
the prevalence of major depressive disorder and any
mood disorder were 8.7% and 16.7%, respectively, in this
population. However, among the patients with major
depressive disorder, the physician recognition rate of
mood disorder was 11.1%. The prescription rate of anti-
depressants to patients with major depressive disorder
was 7.4%. Even in patients who were clinically diagnosed
by physicians as having a mood disorder, the prescription
rate of antidepressants was only 26.7%.
Table 1: Clinical diagnosis of primary illness (n = 312).









Multiple clinical diagnoses were allowed for each patient. The 
total number of clinical diagnosis for all patients was 398.
Five mental disorders as the primary illness are included in 
"Other".
Table 2: Prevalence of depressive disorders.
n % 95% CI
Major depressive disorder 27 8.7 5.5-11.8
Any mood disorder 52 16.7 12.5-20.8
Major depressive disorder and any mood disorder, which was 
defined to include both major depressive disorder and other 
depressive disorders, were assessed by the PHQ.
CI: confidence interval
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In a survey performed nearly 20 years ago using the Com-
posite International Diagnostic Interview (CIDI) at gen-
eral internal medicine outpatient clinics in Japanese
general hospitals, the prevalence of depression was 3.0%
[9]. The prevalence of major depressive disorder in the
present study was higher than that in the previous study.
The previous survey included patients 15-65 years old,
while most of the participants in this study were older
(mean age: 72.9 years old). In addition, the study sites of
the previous survey were located in medium-sized cities
in Nagasaki Prefecture, but the present study was per-
formed in a rural hospital. These differences in patient
characteristics and hospital settings may partly explain
the higher prevalence of depression in the present study.
A meta-analysis of several studies in other countries
showed that the prevalence of depression in primary care
settings for people aged 65 or older is 15.9% [22]. The
prevalence of major depressive disorder in this study was
8.7%, lower than in other countries. This may be partially
due to a difference in medical systems because patients
can directly consult mental health specialists in Japan
rather than being required to consult primary care physi-
cians, as is common in other countries. Meanwhile, in a
previous epidemiological study of people in a Japanese
community, the 12-month prevalence of major depressive
disorder was 2.9% [23]. The lower prevalence in the com-
munity may be reflective of the lower prevalence of
depression diagnosed in a general internal medicine out-
patient clinic. Although a direct comparison is limited by
differences in response rate, age distribution, and survey
method, the prevalence of depression in a general inter-
nal medicine outpatient clinic of a rural hospital in the
present study was higher than the prevalence in the com-
munity. This is consistent with results reported from the
US and UK showing the prevalence of depression in pri-
mary care settings is higher than in the community
[22,24]. This means that depressed patients who have not
received appropriate treatment have consulted general
internists in spite of Japan's medical system that allows
direct consultation to specialists. It is important that phy-
sicians appropriately recognize depressed patients and
treat and/or refer them to mental health specialists.
These physicians can play a role in gatekeeping unrecog-
nized and untreated depressed patients to provide them
with appropriate care.
Recognition
The recognition rate (11.1%) of major depressive disorder
in the present study was lower than the rate of depression
reported in the previous Japanese study (19.3%) [9]. Hos-
pitals in the previous study had their own psychiatric
units, and thus physicians in those hospitals may have
frequently examined patients with psychiatric disorders
and become proficient in diagnosing depression. How-
ever, the hospital in the present study did not have a psy-
chiatry department and no mental health services were
provided by mental health specialists. Despite this differ-
ence between the Japanese studies, both recognition rates
in Japan were much lower than those in other countries
as shown by a meta-analysis (47.3%) [22]. Therefore, as a
first step, it is necessary to increase the recognition rate
of depressed patients by physicians in Japan. Effective
screening of depression [18,19] may be a key activity for
improving depression care.
A simulation in the meta-analysis suggested that when
the prevalence is 10%, there are more false positives (n =
16.8) than either missed (n = 5) or identified cases (n = 5)
for every 100 unselected cases seen in primary care.
There was concern that false positives would increase as
the prevalence decreased [22]. In the present study, not
only the physician recognition rate of depressed patients
was low, but also the false positive rate of was low (3.1%).
This may mean that physicians do not pay attention to
depressive disorder. General internists may think that
care of depression is not "their business" in the Japanese
medical system and that depressed patients should
directly consult mental health specialists. To introduce an
effective screening system, education to increase aware-
ness and to change physician attitudes toward depression
may be important.
Although the severity of mental disorders judged by
physicians correlated with the severity of depression
assessed by the PHQ (Pearson's correlation coefficient r =
0.346, p = 0.012), more than half of the patients with
severe depression were misjudged as having depression of
mild to moderate severity, or having no mental disorder
(58.3%). This result suggests that appropriate care for
depression was not provided even to severely depressed
patients who really needed care. In addition to construct-
ing and implementing a system of screening for depres-
sion, a referral system to mental health specialists and/or
an increase in physician diagnostic and treatment skills is
needed.
Many patients identified with major depressive disor-
der using the PHQ were recognized as having a mental
disorder by physicians, but physicians often clinically
diagnosed the disorder as insomnia, which is a common
symptom of depressive disorders. The higher physician
recognition rate of any mental disorder, such as insomnia,
may be useful in prompting the suspicion of depression.
When a physician notes insomnia and/or a mental disor-
der in a patient, they should at least screen for depression
using a validated screening tool. This step will increase
the recognition rate of probable depression by physicians.
Of patients with major depressive disorder, only two
were prescribed antidepressants and many were pre-
scribed anxiolytics or hypnotics. This may be creating a
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medication. In addition, no patients were referred to
mental health specialists. These results seem consistent
with the higher rate of insomnia clinically diagnosed by
physicians, the lower rate of correct clinical diagnosis of
depression, and the lower estimate of the severity of men-
tal disorders. Even for patients judged by physicians as
having a mood disorder, the prescription rate of antide-
pressants by physicians was low (26.7%). Although it is
controversial whether antidepressants should be pre-
scribed to patients with mild depression in primary care
settings [3,25], the results of the present study suggest
that appropriate care may not always be provided for
depressed patients even when physicians become able to
accurately diagnose depression. Given such a situation,
physicians must at least recognize and monitor depres-
sive disorders to judge the necessity of care and referral to
mental health specialists.
Advantages of the study
No prior study has surveyed recent data of depression
prevalence and physicians' recognition rate of depression
at a general internal medicine outpatient clinic in Japan.
Table 3: Recognition of mental disorders by physicians among patients with major depressive disorder (n = 27) as 
evaluated by the PHQ.
Recognition by 
physician
Clinical diagnosis by 
physician
n % of patients with major 
depressive disorder
n % of patients with major 
depressive disorder
Any mental disorder 21 77.8
Mood disorder 3 11.1








No mental disorder 6 22.2
Because multiple answers were allowed in the clinical psychiatric diagnosis, the total number of diagnoses was 28 and the number of diagnoses 
per patient was 1.33 for patients with major depressive disorder. Also, the numbers for anxiety and insomnia include patients diagnosed with a 
mood disorder: a1, b2.




Clinical diagnosis by 
physician
n % of patients with any 
mood disorder





Mood disorder 7 13.5








No mental disorder 21 40.4
Because multiple answers were allowed in the clinical psychiatric diagnosis, the total number of diagnoses was 41 and the number of 
diagnoses per patient was 1.32 for patients with any mood disorder. Also, the numbers for anxiety and insomnia include patients diagnosed 
with a mood disorder: a3.
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rates of antidepressants to all consulted patients.
The present study was performed in a hospital located
in a rural area where the proportion of the elderly is high.
Generally, medical resources are poorer in rural areas
than in urban areas, and elderly people have more
chronic physical illnesses. Thus, general internal medi-
cine in a rural area has an important primary care role in
the community, especially for the elderly. In fact, most
participants in the present study were geriatric patients.
The findings are useful for constructing an effective inter-
vention model to care for depressed patients in rural
areas in Japan.
The rate of patients who did not participate in a similar
survey performed in a rural French area using the PHQ
was 14.1% (11.4% refused to participate, and 2.7% did not
have enough to time to answer) [26]. The rate of patients
who did not participate in the present study was half
(7.1%) that of the French study. This suggests that the bias
caused by refusal to participate in the present study may
be smaller than that of the previous study. Furthermore,
the rate of patients who did not participate in the survey
using the Structured Clinical Interview for DSM-IV
(SCID) was more than 40% [27]. Use of the PHQ instead
of a semi-structured interview is one reason for the
increased rate of participants. However, the bias from
using the PHQ, which is a self-administered question-
naire, instead of a semi-structured interview may be
unavoidable, as discussed in the following section.
Limitations of the study
The present study has several limitations. First, as dis-
cussed above, we used self-administered questionnaires
(the PHQ and the GAD-7) to evaluate depressive disor-
ders and comorbid psychiatric disorders. The PHQ
addresses symptoms only for a two-week period and may
include bereavement reactions, mood disorders caused
by physical disorders or medications, and/or depressive
episodes of bipolar disorders. Although the Japanese
PHQ has high sensitivity and specificity for major depres-
sive disorder, evaluation using a diagnostic interview,
such as the semi-structured clinical interview for DSM-
IV, will increase the validity of the results. Second, we
surveyed only five physicians in one hospital. To increase
the generalizability of the present results, a study includ-
ing multiple hospitals or clinics is needed. Third, we
judged cognitive impairment based on brief semi-struc-
tured interviews of patients or accompanying persons.
Sometimes it is difficult to discriminate between depres-
sion and cognitive impairments caused by dementia in
the geriatric population. A study using a screening or
diagnostic tool with higher performance to exclude cog-
nitive impairment is needed. Finally, we surveyed a his-
tory of psychotropic medicine prescription on the
consultation day. However, the prescription may be
reflected behavior by previous physicians rather than the
one carrying out the current diagnosis.
Conclusions
The prevalence of depression at a general internal medi-
cine outpatient clinic was higher in the present study
than in the Japanese community. Thus, general internists
can play a role as gatekeepers for diagnosing untreated
depressed patients in the community. However, physi-
cians did not recognize depressed patients, even in severe
cases. The prescription rate of antidepressants to
depressed patients and the referral rate of depressed
patients to mental health specialists were also low. In
addition, the prescription rate of antidepressants to
patients whom physicians diagnosed as having a mood
disorder was also low.
There are multiple barriers to providing appropriate
care for patients with depression, such as recognition of
depression, judgment of its severity, prescription of anti-
depressants and referral to mental health specialists. Col-
laborative care models developed and shown to be
effective in the US and UK [5] to care for depressed
patients by general practitioners and primary care physi-
cians cannot be applied directly to the Japanese medical
system.





n % n %
Antidepressant (including sulpiride) 2 7.4 5 9.6
Anxiolytic/Hypnotic 16 59.3 22 42.3
No psychotropic medicine 11 40.7 29 55.8
% is in patients with depressive disorder evaluated by the PHQ.
Patients prescribed both antidepressant and anxiolytic/hypnotic: Major depressive disorder (2), any mood disorder (4).
One patient with major depressive disorder who was prescribed an antidepressant from another hospital was not included. 
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Page 9 of 9Physicians can recognize insomnia comorbid with
depression and can judge the presence of a mental disor-
der in depressed patients. Thus, an important step is to
change physicians' attitude to depression into "it is our
business" to find depression. The additional step is to per-
form screening and then to monitor the screening-posi-
tive patients and to refer them to mental health
specialists. In addition to constructing a screening and
monitoring system of depression, an educational inter-
vention for physicians is key for improving the quality of
life of depressed patients at general internal medicine
outpatient clinics and of missed depressed patients in the
community.
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